Skip to content
Sign in

USPH · NYSE

U.S. Physical Therapy (USPH) Stock Price & Fundamentals

$577.93−1.35%−$7.91End-of-day price as of Oct 9, 2026

U.S. Physical Therapy (USPH) closed at $577.93 on Oct 9, 2026, down 1.35% from the previous close of $585.84.

Share price, past year

1Y +27.02%

52-week range $433.33 – $603.30. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$577.93
Sep 30, 2026$590.41
Aug 31, 2026$580.34
Jul 31, 2026$571.57
Jun 30, 2026$562.60
May 29, 2026$570.40
Apr 30, 2026$548.82
Mar 31, 2026$511.24
Feb 27, 2026$506.28
Jan 30, 2026$495.94
Dec 31, 2025$465.42
Nov 28, 2025$456.74
Oct 31, 2025$439.32

Key statistics

Market cap
$8.62B
P/E (TTM)
3,399.6
EPS (TTM)
$0.17
Revenue (TTM)
$812.20M
Net income (TTM)
$32.23M
Shares outstanding
14.9M
Dividend yield
0.31%
52-week range
$433.33 – $603.30

U.S. Physical Therapy's market cap is $8.62B, based on a share price of $577.93 and 14.9M shares outstanding as of Aug 7, 2026.

Financials

U.S. Physical Therapy reported revenue of $780.99M for fiscal 2025, up 16.33% from fiscal 2024.

U.S. Physical Therapy earned net income of $39.58M in fiscal 2025, a net margin of 5.1%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
U.S. Physical Therapy annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$780.99M+16.3%$39.58M5.1%$1.42—
FY2024ended Dec 31, 2024$671.35M+11.0%$31.42M4.7%$1.84—
FY2023ended Dec 31, 2023$604.80M+9.3%$28.24M4.7%$1.28—
FY2022ended Dec 31, 2022$553.14M+11.7%$32.16M5.8%$2.25—
FY2021ended Dec 31, 2021$495.02M+17.0%$40.83M8.3%$2.41—
FY2020ended Dec 31, 2020$422.97M−12.2%$35.19M8.3%$2.48—
FY2019ended Dec 31, 2019$481.97M+6.2%$40.04M8.3%$2.45—
FY2018ended Dec 31, 2018$453.91M+9.6%$34.87M7.7%$1.31—
FY2017ended Dec 31, 2017$414.05M+16.1%$22.26M5.4%$1.76—
FY2016ended Dec 31, 2016$356.55M—$20.55M5.8%$1.64—
U.S. Physical Therapy quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$214.06M$9.90M$0.25
Q1 FY2026ended Mar 31, 2026$198.29M$5.04M−$0.12
Q4 FY2025ended Dec 31, 2025$202.73M$4.15M−$0.44
Q3 FY2025ended Sep 30, 2025$197.13M$13.14M$0.48
Q2 FY2025ended Jun 30, 2025$197.34M$12.39M$0.58
Q1 FY2025ended Mar 31, 2025$183.79M$9.90M$0.80
Q4 FY2024ended Dec 31, 2024$180.45M$9.24M$0.52
Q3 FY2024ended Sep 30, 2024$168.03M$6.63M$0.39

Company profile

Name
U.S. Physical Therapy, Inc.
Ticker
USPH
Exchange
NYSE
Industry (SEC SIC)
Services-Health Services
Headquarters
1300 West Sam Houston Parkway South, Suite 300, Houston, TX 77043
Incorporated in
NV
Fiscal year ends
December
SEC CIK
0000885978

Recent SEC filings

Frequently asked questions

What is U.S. Physical Therapy's stock price?

U.S. Physical Therapy (USPH) closed at $577.93 on Oct 9, 2026, down 1.35% from the previous close of $585.84.

What is U.S. Physical Therapy's market cap?

U.S. Physical Therapy's market cap is $8.62B, based on a share price of $577.93 and 14.9M shares outstanding as of Aug 7, 2026.

How much revenue does U.S. Physical Therapy make?

U.S. Physical Therapy reported revenue of $780.99M for fiscal 2025, up 16.33% from fiscal 2024.

What is USPH's P/E ratio?

U.S. Physical Therapy's price-to-earnings ratio is 3,399.6, based on trailing twelve-month diluted EPS of $0.17.

Does U.S. Physical Therapy pay a dividend?

Yes. U.S. Physical Therapy declared $1.82 per share in dividends over the last four quarters, a yield of 0.31%.

Sources and methodology

Fundamentals come from U.S. Physical Therapy, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures